ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT06351644 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study closure is due to insufficient supply of study drug.

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: ON 123300
DRUG: Dexamethasone

Sponsor

Adriana Rossi